1-[Bis(4-fluorophenyl)methyl]piperazine
Properties
- Molecular formula
- C17H18F2N2
- Molar mass
- 288.34 g/mol
- Exact mass
- 288.1438 Da
- Melting point
- 88–91 °C
- logP
- 2.96Crippen estimate
- Polar surface area
- 15.3 Ų
- H-bond donors / acceptors
- 1 / 2
- Rotatable bonds
- 3
Hazards
Danger
- H301 Toxic if swallowed100% of notifiers
- H315 Causes skin irritation91.5% of notifiers
- H319 Causes serious eye irritation91.5% of notifiers
- H335 May cause respiratory irritation89.4% of notifiers
Aggregated from 47 ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Precautionary statements
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, P501
Identifiers
CAS number
27469-60-9SMILES
Fc1ccc(C(c2ccc(F)cc2)N2CCNCC2)cc1InChIKey
TTXIFFYPVGWLSE-UHFFFAOYSA-NInChI
InChI=1S/C17H18F2N2/c18-15-5-1-13(2-6-15)17(21-11-9-20-10-12-21)14-3-7-16(19)8-4-14/h1-8,17,20H,9-12H2Weigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
10 names
- Piperazine, 1-[bis(4-fluorophenyl)methyl]-
- Piperazine, 1-[bis(p-fluorophenyl)methyl]-
- 1-(Di-p-fluorobenzhydryl)piperazine
- R 19352
- T 841
- N-(4,4′-Difluorobenzhydryl)piperazine
- N-(Bis(4-fluorophenyl)methyl)piperazine
- 4-[Bis(4-fluorophenyl)methyl]piperazine
- 4,4′-Difluorobenzhydrylpiperazine
- 1-(Bis(4-fluorophenyl)methyl)piperazine
Work with 1-[Bis(4-fluorophenyl)methyl]piperazine
Similar compounds
1-(4-Fluoro-alpha-phenylbenzyl)piperazine27064-89-787 % similar
Diphenylmethylpiperazine841-77-063 % similar
1-(4,4'-Dichlorobenzhydryl)piperazine27469-61-063 % similar
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine130018-88-156 % similar
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine300543-56-056 % similar
Norchlorcyclizine303-26-456 % similar
1-(4-Fluorophenyl)piperazine2252-63-353 % similar
4-(4-Fluorophenyl)piperidine37656-48-753 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.